What is the typical lead time for orders?

The average lead time is 1-3 months for both peak season and off-season periods.

Which international markets does the company serve?

Products are exported to over 70 countries, including markets in Asia, South America, Africa, CIS Countries, the Middle East, and Europe.

High Quality Antipyretics Diclofenac Sodium Enteric-Coated Tablets

Name: High Quality Antipyretics Diclofenac Sodium Enteric-Coated Tablets
Brand: Reyoung Pharmaceutical Co., Ltd.
SKU: 1940404042

Shandong, ChinaReyoung Pharmaceutical Co., Ltd.

US$0.10-1.00

30,000 box

Product profile

Customization

Available

Transport Package

10tabs/Blister

Trademark

Reyoung

Model NO.

25mg; 50mg; 100mg

Origin

China Reyoung

HS Code

30049090

Key features

Comprehensive Pain Relief: Effective for rheumatism, gout, post-traumatic pain, toothache, headache, and dysmenorrhea.

Antipyretic for All Ages: Provides fever reduction for both adults and children with diclofenac sodium enteric-coated tablets.

GMP Certified Manufacturer: Certified by GMP, ISO9001, ISO14001, and OHS18001 with over 20 years of international experience.

Massive Production Capacity: Annual output of 4 billion tablets, 6 billion capsules, and 2.5 billion vials of powder for injection.

Global Market Presence: Products exported to over 70 countries across Asia, South America, Africa, CIS, Middle East, and Europe.

OEM and ODM Services: Offers customized manufacturing solutions with 370 R&D engineers and advanced production facilities.

Flexible Payment Terms: Accepts LC, T/T, and D/P payment methods to facilitate international transactions.

Established Brand Reputation: 'REYOUNG' is a famous trademark in China with a history dating back to 1966.

Company profile

Reyoung Pharmaceutical Co., Ltd.

Shandong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2020-10-13 CertifiedNearest Port: Qingdao PortAverage Response Time: ≤24h CertifiedTerms of Payment: LC, T/T, D/P

AI-Powered supplier vetting

SummaryReyoung Pharmaceutical Co., Ltd. is a China-based limited company established in 1998, with 4,950 employees and operations in Shandong. The available information identifies it as a pharmaceutical manufacturer supplying injectable antibiotics, oral solid medicines, veterinary cefotaxime sodium sterile, and lyophilized products. It reports more than 10 production lines, 370 years of combined R&D engineer experience, 50 quality-control staff, and ISO9001, ISO14001, and ISO45001 certifications. Export sales represent 31%–40% of total sales, with exporting reported since 2020 in one record and since 1998 in the company description, creating a discrepancy. Trade records show limited documented transactions and associated buyers in Bolivia, India, and Vietnam. Evidence is insufficient to assess after-sales service, financial credibility, customization, or verified customer performance comprehensively.

Supplier typeThe supplier is identified as a limited company and pharmaceutical manufacturer based in Shandong, China. Its stated products include injectable cephalosporins and penicillins, oral solid medicines, lyophilized products, and veterinary medicines, indicating a combined manufacturing and commercial business profile.

CertificationsThe supplier reports ISO9001:2015, ISO14001:2015, and ISO45001:2016 management-system certificates, along with cGMP, PIC/S, and ANVISA GMP holdings. These claims directly support established quality, environmental, occupational-safety, and pharmaceutical GMP capability, although certificate validity and scope are not independently shown.

R&D capabilityThe supplier reports 370 years of total R&D engineer experience and offers multiple dosage forms and pharmaceutical categories, including lyophilized products and injectable antibiotics. These details support R&D resources and product-development breadth, but no information confirms proprietary technologies, new product launches, patents, or development outcomes.

Production capacityProduction capability is supported by 4,950 employees, more than 10 production lines, pharmaceutical manufacturing descriptions, and product records for injectable antibiotics and veterinary cefotaxime sodium sterile. The plant-area entry is recorded as 0.0m², which is unusable or inconsistent data, so facility scale cannot be confirmed from that field.

Client casesTrade-related records associate the supplier with buyers in Bolivia, India, and Vietnam and show documented transactions for oral rehydration products, cefotaxime acid, and ceftriaxone sodium for injection. The records show some international commercial activity, but the number of stated transactions is limited and no customer testimonials, repeat-order evidence, or performance evaluations are provided.

Product Q&A

Q:What are the main indications for Diclofenac Sodium Enteric-Coated Tablets?

Indications include inflammatory and degenerative rheumatism (rheumatoid arthritis, osteoarthritis), non-articular rheumatic diseases, acute gout attacks, post-traumatic/postoperative pain, toothache, headache, gynecological pain, and antipyretic effect for adults and children.

Q:What certifications does Reyoung Pharmaceutical hold?

Reyoung Pharma is certified by GMP, ISO9001, ISO14001, and OHS18001. It has also passed GMP inspections in countries like Colombia, Peru, Pakistan, Ukraine, and the Philippines.

Q:What is the annual production capacity of the manufacturer?

The annual capacity includes 4 billion tablets, 6 billion capsules, 200 million bags of granules, 2.5 billion vials of powder for injection, 300 million ampoules of liquid injection, and 2000 tons of API.

Q:Does the supplier offer OEM or ODM services?

Yes, Reyoung Pharma offers both OEM and ODM services, supported by 370 R&D engineers and advanced production machines.

Q:What are the available payment terms?

The accepted payment terms are LC (Letter of Credit), T/T (Telegraphic Transfer), and D/P (Documents against Payment).